Are you worried about how others see your basal cell carcinomas?

The Pelle-926-301 Study is researching an investigational medication that may reduce the disease burden of basal cell carcinomas from Gorlin Syndrome on your face.

Find a participating
research site

Study site locations.

If you’re interested in taking part in this study, enter your zip code below or select the map to find the participating site(s) nearest you.

View full list of locations.

Active Site Active site locations
Future Site Future site locations